MELINTA THERAPEUTICS INC's ticker is MLNTXXXX and the CUSIP is 58549G100. A total of 3 filers reported holding MELINTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $28,000 | -96.1% | 35,156 | -80.6% | 0.00% | – |
| Q3 2018 | $716,000 | +54.0% | 181,292 | +147.4% | 0.00% | – |
| Q2 2018 | $465,000 | +161.2% | 73,286 | +204.1% | 0.00% | – |
| Q1 2018 | $178,000 | -85.4% | 24,097 | -68.7% | 0.00% | -100.0% |
| Q4 2017 | $1,217,000 | – | 77,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISTHMUS PARTNERS, LLC | 84,072 | $7,657,000 | 1.86% |
| Sterling Investment Advisors, Ltd. | 19 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |